Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion. Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.
For decades, HSBC, one of the world's largest banks, laundered hundreds of millions of dollars for Mexican drug cartels. Senator Elizabeth Warren, dogged journalists and prosecutors try to hold the bankers to account.
In Canada, maple syrup is worth more than oil. When $20 million of syrup goes missing, the trail leads back to an epic battle between cartels and the little guy.
Weaving together a tapestry of tales in real estate booms and busts, Stevens lays out how Donald Trump's business career transformed from epic failures into a consummate branding machine that propelled him into office.
It all begins as a study on the psychology of prison life led by Stanford psychology professor Dr. Philip Zimbardo. 24 volunteers - 12 guards and 12 prisoners - have agreed to spend the next two weeks recreating life in a correctional facility. Normal people can become monsters, given the right situation, that's the standard narrative of the Stanford Prison Experiment, one of the most famous psychological experiments of all time. But what if the cause of its participants' cruel behavior wasn't what we've always been told?
Someday, I will die. But should I? If I was offered a longer life, I would take that in a second. But how long is too long? Is death something I should deny forever, or is death and the role it plays in the universe something I am better off accepting?
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.